Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 3:21 pm Unchanged | 13G | VERA THERAPEUTICS INC VERA | Ares Trading S.A. | 1,913,501 3.6% | 0 (Unchanged) | View |
| 2024-02-14 3:20 pm Unchanged | 13G | INTREXON CORP XON | Ares Trading S.A. | 20,647,152 8.3% | 0 (Unchanged) | View |
| 2023-01-27 09:29 am Unchanged | 13G | INTREXON CORP XON | Ares Trading S.A. | 20,647,152 9.92% | 0 (Unchanged) | View |
| 2023-01-27 06:17 am Unchanged | 13G | VERA THERAPEUTICS INC VERA | Ares Trading S.A. | 1,913,501 6.92% | 0 (Unchanged) | View |
| 2022-01-24 10:04 am Sale | 13G | INTREXON CORP XON | Ares Trading S.A. | 20,647,152 9.99% | -6,751,367 (-24.64%) | View |
| 2022-01-24 10:01 am Purchase | 13G | VERA THERAPEUTICS INC VERA | Ares Trading S.A. | 1,913,501 8.99% | 1,913,501 (New Position) | View |
| 2021-01-08 11:52 am Purchase | 13G | INTREXON CORP XON | Ares Trading S.A. | 27,398,519 14.8% | 2,546,171 (+10.25%) | View |
| 2020-01-22 06:38 am Purchase | 13G | INTREXON CORP XON | Ares Trading S.A. | 24,852,348 14.9% | 772,209 (+3.21%) | View |